Wang, Xinghao http://orcid.org/0000-0001-8264-8537
Zou, Weiping
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA217648, CA123088, CA099985, CA193136, CA152470, CA46592)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM007863)
Article History
First Online: 4 December 2023
Competing interests
: W.Z. has served as a scientific advisor or consultant for Cstone, ProteoVant, NextCure, Regeneron, and Intergalactic.